The Comparison of Hemostatic Effects of Recombinant Activated Factor VII (rFVIIa) in Thrombocytopenic Patients (pts) and Hemophilia Pts with Inhibitors

被引：0
|
作者：
Galstian, Gennadii M. [1 ]
Kolosova, Irina V. [1 ]
Gemdzhian, Eduard [2 ]
Zorenko, Vladimir Yu. [3 ]
Polyanskaya, Tatyana A. [4 ]
Orel, Elena B. [5 ]
Savchenko, Valeri G. [6 ]
机构：
[1] Natl Res Ctr Hematol, ICU, Moscow, Russia
[2] Natl Res Ctr Hematol, Biostat, Moscow, Russia
[3] Natl Res Sci Ctr Hematol, Moscow, Russia
[4] Natl Res Sci Ctr Hematol, Dept Orthoped Surg, Moscow, Russia
[5] Natl Res Ctr Hematol, Lab Clin Coagulol, Moscow, Russia
[6] Natl Res Ctr Hematol, Moscow, Russia
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Continuous infusion of recombinant activated factor VII: a review of data in congenital hemophilia with inhibitors and congenital factor VII deficiency
    Rajpurkar, Madhvi
    Cooper, David L.
    [J]. JOURNAL OF BLOOD MEDICINE, 2018, 9 : 227 - 239
  • [42] Use of recombinant activated factor VII for surgical interventions in patients with inhibitor hemophilia
    Polyanskaya, T. Yu.
    Zorenko, V. Yu.
    Karpov, E. E.
    [J]. GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2008, 53 (03): : 3 - 5
  • [43] COST MINIMIZATION ANALYSIS OF ACTIVATED PROTHROMBIN COMPLEX CONCENTRATE (APCC) COMPARED TO RECOMBINANT FACTOR VIIA (RFVIIA) FOR HEMOPHILIA PATIENTS WITH INHIBITORS
    Mlcoch, T.
    Klimes, J.
    Dolezal, T.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A533 - A533
  • [44] Use of recombinant activated factor vii (rFVIIa) in patients with uncontrolled bleeding: an evaluation of professional practices
    Langevin, Sophie
    Liou, Amelie
    Bignon, Estelle
    Vaissier, Elisabeth
    Ouattara, Alexandre
    Farinotti, Robert
    [J]. PHARMACY WORLD & SCIENCE, 2008, 30 (05): : 709 - 710
  • [45] Recombinant activated coagulation factor VII (rFVIIa) as an adjunctive hemostatic therapy in patients with multiple system organ failure and acute upper gastrointestinal bleeding
    S Milanov
    M Milanov
    E Gyurov
    Z Shterev
    [J]. Critical Care, 7 (Suppl 2):
  • [46] Home treatment of hemarthrosis with recombinant activated factor VII (rFVIIa) in patients with haemophilia A or B and inhibitors: experience from developing countries
    Belhani, Meriem Fadila
    Al Momen, Abdel Kareem
    El Fegoun, Soraya Benchikh
    Hamzy, Fati
    Mehalhal, Nemra Giad
    Khalifa, Habiba Hadj
    Hamdi, Selma
    Owaida, Tarek
    Saad, Hossam Ali
    Wali, Yasser Ahmed Soliman
    [J]. HAEMOPHILIA, 2014, 20 : 16 - 17
  • [47] Combination therapy with activated prothrombin complex concentrate (APCC) and recombinant factor VIIa (rFVIIa) in patients with severe hemophilia and inhibitors.
    Schneiderman, J
    Nugent, DJ
    Young, G
    [J]. BLOOD, 2002, 100 (11) : 696A - 696A
  • [48] Cost utility of knee surgery with recombinant activated factorvii (rFVIIa) in hemophilia patients with inhibitors: An exploratory model
    Botteman, M. F.
    Ballal, R.
    Joshi, A., V
    [J]. VALUE IN HEALTH, 2007, 10 (06) : A282 - A283
  • [49] SUCCESSFUL PROPHYLACTIC USE OF RECOMBINANT ACTIVATED FACTOR VII (RFVIIA) IN A PATIENT WITH CONGENITAL FVII DEFICIENCY AND INHIBITORS TO FVII
    Tokgoz, H.
    Caliskan, U.
    Lavigne-Lissalde, G.
    Giansily-Blaizot, M.
    [J]. HAEMATOLOGICA, 2012, 97 : 514 - 515
  • [50] In vivo clearance and metabolism of recombinant activated factor VII (rFVIIa) and its complexes with plasma protease inhibitors in the liver
    Seested, T.
    Appa, R. S.
    Christensen, E. I.
    Ioannou, Y. A.
    Krogh, T. N.
    Karpf, D. M.
    Nielsen, H. M.
    [J]. THROMBOSIS RESEARCH, 2011, 127 (04) : 356 - 362
12345